Inhibition of EP4 signaling attenuates aortic aneurysm formation.

PloS One
Utako YokoyamaYoshihiro Ishikawa

Abstract

Aortic aneurysm is a common but life-threatening disease among the elderly, for which no effective medical therapy is currently available. Activation of prostaglandin E(2) (PGE(2)) is known to increase the expression of matrix metalloproteinase (MMP) and the release of inflammatory cytokines, and may thus exacerbate abdominal aortic aneurysm (AAA) formation. We hypothesized that selective blocking of PGE(2), in particular, EP4 prostanoid receptor signaling, would attenuate the development of AAA. Immunohistochemical analysis of human AAA tissues demonstrated that EP4 expression was greater in AAA areas than that in non-diseased areas. Interestingly, EP4 expression was proportional to the degree of elastic fiber degradation. In cultured human aortic smooth muscle cells (ASMCs), PGE(2) stimulation increased EP4 protein expression (1.4 ± 0.08-fold), and EP4 stimulation with ONO-AE1-329 increased MMP-2 activity and interleukin-6 (IL-6) production (1.4 ± 0.03- and 1.7 ± 0.14-fold, respectively, P<0.05). Accordingly, we examined the effect of EP4 inhibition in an ApoE(-/-) mouse model of AAA infused with angiotensin II. Oral administration of ONO-AE3-208 (0.01-0.5 mg/kg/day), an EP4 antagonist, for 4 weeks significantly decreased the...Continue Reading

References

Aug 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·T FreestoneJ T Powell
May 1, 1997·Journal of Vascular Surgery·D R HolmesJ M Reilly
May 26, 1998·Biochemical and Biophysical Research Communications·E SegiA Ichikawa
Jun 7, 2000·The Journal of Clinical Investigation·A DaughertyL A Cassis
Oct 17, 2001·The Journal of Clinical Investigation·C NatarajT M Coffman
Apr 3, 2002·The Journal of Clinical Investigation·Kenji KabashimaShuh Narumiya
Sep 5, 2002·The Journal of Clinical Investigation·G Matthew LongoB Timothy Baxter
Sep 7, 2002·The Journal of Biological Chemistry·Kiyoshi TakayamaPeter Libby
Jul 10, 2003·Cytokines, Cellular & Molecular Therapy·Vladislav TreskaZbynek Tonar
Mar 17, 2004·The Journal of Biological Chemistry·K M Faisal KhanDomenick J Falcone
Jul 16, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco CipolloneAndrea Mezzetti
Nov 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Utako YokoyamaYoshihiro Ishikawa
Nov 29, 2005·Nature Medicine·Koichi YoshimuraMasunori Matsuzaki
Mar 4, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Victoria L KingCharles D Loftin
Dec 2, 2006·Cardiovascular Research·Jonathan M GitlinCharles D Loftin
Dec 22, 2006·Annals of the New York Academy of Sciences·Dong-Chuan GuoDianna M Milewicz
Feb 9, 2008·World Journal of Surgery·Suman AnnambhotlaChangyi Chen
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Jun 11, 2009·Clinical and Experimental Dermatology·M KurzawskiM Droździk
Nov 20, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michel SteenportDomenick J Falcone
Nov 23, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Eva H C TangPeter Libby

❮ Previous
Next ❯

Citations

Jul 27, 2012·Current Atherosclerosis Reports·Hong LuAlan Daugherty
May 21, 2015·International Journal of Molecular Sciences·Albert M Kroon, Jan-Willem Taanman
Mar 26, 2013·Pharmacology & Therapeutics·Viktoria KonyaAkos Heinemann
Sep 7, 2016·Oxidative Medicine and Cellular Longevity·Guangrui Yang, Lihong Chen
Sep 11, 2016·The Journal of Physiological Sciences : JPS·Kayoko OdaYoshihiro Ishikawa
Mar 16, 2017·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Lara T MeitalFraser D Russell
Dec 22, 2016·The Journal of Physiological Sciences : JPS·Utako YokoyamaYoshihiro Ishikawa
Oct 18, 2013·Journal of Lipid Research·Mercedes CamachoLuis Vila
Mar 26, 2013·Circulation Research·Darshini B TrivediRobert Langenbach
Oct 23, 2013·Circulation·Utako YokoyamaYoshihiro Ishikawa
Jul 14, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Utako YokoyamaYoshihiro Ishikawa
Jun 19, 2013·Pharmacological Reviews·Utako YokoyamaYoshihiro Ishikawa
Aug 14, 2019·International Journal of Molecular Sciences·Łukasz GutowskiDorota Formanowicz
Jan 28, 2020·ESC Heart Failure·Ryo TanakaYoshihiro Ishikawa
Apr 24, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Taro HiromiYoshihiro Ishikawa
Feb 18, 2017·PloS One·Wenrui HaoDai Zhu
Oct 24, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G OzenX Norel
Nov 23, 2019·Cancer Science·Kohei OsawaYoshihiro Ishikawa
Apr 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Hu XuYoufei Guan
Feb 16, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Hui MaWen-Jiang Yan
Sep 12, 2020·British Journal of Pharmacology·Jonathan GolledgeYutang Wang
Nov 26, 2021·Biochemical Pharmacology·Timothy D Bryson, Pamela Harding

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
PMA
pharmacotherapy

Software Mentioned

Keyence

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Cardiac Aneurysm

Aneurysm refers to a bulge of the wall or lining of a vessel commonly occurring in the blood vessels at the base of the septum or within the aorta. In the heart, it usually arises from a patch of weakened tissue in a ventricular wall, which swells into a bubble filled with blood. Discover the latest research on cardiac aneurysm here.